14 Jun 2019 administrator Uncategorized “Impressive” results of a new approach to relapsed or refractory Hodgkin lymphoma Phase 2 study finds that a new treatment combination may improve outcomes for people with relapsed or refractory Hodgkin lymphoma. A recent,